SEC Form 4 · accession 0001013606-15-000018
ENDOLOGIX INC /DE/ · ELGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Shelley B Thunen
Officer — Chief Financial Officer
Period of report
Feb 27, 2015
Accepted (ET)
Mar 2, 2015 · 4:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013606
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 27, 2015 | A | 3,820 | $0.00 | A | 56,622 | D | |
| Common Stock | Feb 27, 2015 | F | 1,673 | $15.77 | D | 54,949 | D |
Table II — derivative securities
No Table II lines on this filing.